Angiomyolipoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Angiomyolipoma}} | {{Angiomyolipoma}} | ||
{{CMG}}''' Associate Editor-In-Chief:''' {{CZ}} | {{CMG}}''' Associate Editor-In-Chief:''' {{CZ}}, {{Faizan}} | ||
==Incidence== | ==Incidence== | ||
The incidence is about 0.3-3%. It occurs in more than 50% of individuals with [[tuberous sclerosis]], often bilaterally. | The incidence is about 0.3-3%. It occurs in more than 50% of individuals with [[tuberous sclerosis]], often bilaterally. | ||
==Gender== | ==Gender== | ||
Angiomyolipoma is twice as common in females as in males. | Angiomyolipoma is twice as common in females as in males. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 13:56, 21 September 2015
|
Angiomyolipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Angiomyolipoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Angiomyolipoma epidemiology and demographics |
|
Risk calculators and risk factors for Angiomyolipoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Faizan Sheraz, M.D. [3]
Incidence
The incidence is about 0.3-3%. It occurs in more than 50% of individuals with tuberous sclerosis, often bilaterally.
Gender
Angiomyolipoma is twice as common in females as in males.